Literature DB >> 1784528

Diarrheal disease due to Clostridium difficile in general practice.

T V Riley1, F Wetherall, J Bowman, J Mogyorosy, C L Golledge.   

Abstract

A total of 288 stool samples from patients attending their general practitioners was examined for the presence of Clostridium difficile. C. difficile or its cytotoxin was found in 16 patients (5.5%) and was the most common enteric pathogen detected. Most patients had only mild to moderate diarrhea but in the majority of patients the diarrhea was protracted. Eleven of the 16 patients had received antimicrobial agents in the 3 mths preceding onset of diarrhea and there was good circumstantial evidence that 2 other patients had also been exposed. None of the patients had a history of any inflammatory bowel disease or possible occupational exposure. The prescribing habits of general practitioners with regard to antimicrobial agents were monitored for a 1 yr period. Tetracyclines and amoxycillin accounted for approximately 25% each of all prescriptions dispensed. Ten of the 16 patients were treated with antimicrobials (mainly metronidazole) and in most cases the diarrhea resolved. We conclude that C. difficile may be a significant cause of community-acquired diarrhea.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1784528     DOI: 10.3109/00313029109063603

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  8 in total

1.  Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital.

Authors:  Tara N Palmore; SeJean Sohn; Sharp F Malak; Janet Eagan; Kent A Sepkowitz
Journal:  Infect Control Hosp Epidemiol       Date:  2005-08       Impact factor: 3.254

Review 2.  Pathogenesis and treatment of Clostridium difficile infection.

Authors:  I Tonna; P D Welsby
Journal:  Postgrad Med J       Date:  2005-06       Impact factor: 2.401

3.  Clostridium difficile: a pathogen of the nineties.

Authors:  T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-03       Impact factor: 3.267

4.  The incidence and clinical symptomatology of Clostridium difficile infections in a community setting in a cohort of Danish patients attending general practice.

Authors:  L M Søes; H M Holt; B Böttiger; H V Nielsen; M Torpdahl; E M Nielsen; S Ethelberg; K Mølbak; V Andreasen; M Kemp; K E P Olsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-12-19       Impact factor: 3.267

5.  Clostridium difficile after antibiotic therapy.

Authors:  F Habib; D Reeves; A MacGowan
Journal:  Br J Gen Pract       Date:  1994-07       Impact factor: 5.386

Review 6.  The changing epidemiology of Clostridium difficile infections.

Authors:  J Freeman; M P Bauer; S D Baines; J Corver; W N Fawley; B Goorhuis; E J Kuijper; M H Wilcox
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

7.  Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county.

Authors:  T Norén; T Akerlund; E Bäck; L Sjöberg; I Persson; I Alriksson; L G Burman
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

Review 8.  Epidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative Review.

Authors:  Lauren E Bloomfield; Thomas V Riley
Journal:  Infect Dis Ther       Date:  2016-07-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.